Clinical trial
RECARE (REnal Safety Following the Intra-Arterial Administration of Iopamidol vs. Iodixanol During Coronary AngiogRaphy in DiabEtic Patients)
NCT00782639 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RECARE (REnal Safety Following the Intra-Arterial Administration of Iopamidol vs. Iodixanol During Coronary AngiogRaphy in DiabEtic Patients)
- Lead sponsor
- Bracco Diagnostics, Inc
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- March 31, 2009
- Completion date
- September 30, 2009
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic renal impairment, diabetes mellitus